News Headline Summary
AstraZeneca (AZN LN) says no boost from baseline in mean daily Opioid dose
- Co. announces results from long-term safety trial of Naloxegol in patients with Opioid induced constipation.
Reaction details (11:34)
- Co. shares unreactive, trades down 0.97% at GBP 29.49 last.
26 Feb 2013 - 11:31
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
Teams of analysts covering equities, fixed income, FX, energy, and metals markets
Real-time scrolling news service with instant analysis
Daily and weekly pre-market research and calendars
Video updates covering near-term key risk events & primary trading themes
One-to-one chat with our expert analysts